MRKR - Marker Therapeutics Inc
1.11
-0.030 -2.703%
Share volume: 19,543
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.14
-0.03
-0.03%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-14-2023 | 11-09-2023 | 11-14-2024 | 05-15-2024 | 08-14-2024 | 11-14-2024 | |
| Total revenue | 1.234 M | 762.658 K | 257.606 K | 1.057 M | 1.244 M | 1.169 M | 1.926 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.234 M | 762.658 K | 257.606 K | 1.057 M | 1.244 M | 1.169 M | 1.926 M | |
| -38.21% | -66.22% | 310.14% | 17.75% | -6.01% | 64.72% | |||
| Operating expenses | 5.544 M | 4.897 M | 3.458 M | 3.994 M | 3.793 M | 3.477 M | 4.326 M | |
| Selling general and admin | 2.167 M | 2.519 M | 1.413 M | 1.377 M | 1.218 M | 1.142 M | 854.677 K | |
| Research and development | 3.376 M | 2.378 M | 2.045 M | 2.617 M | 2.575 M | 2.335 M | 3.471 M | |
| Total expenses | 5.544 M | 4.897 M | 3.458 M | 3.994 M | 3.793 M | 3.477 M | 4.326 M | |
| -11.67% | -29.39% | 15.52% | -5.04% | -8.33% | 24.40% | |||
| Operating income | -4.309 M | -4.134 M | -3.200 M | -2.938 M | -2.549 M | -2.308 M | -2.400 M | |
| Ebit | -4.309 M | -4.134 M | -3.200 M | -2.938 M | -2.549 M | -2.308 M | -2.400 M | |
| Pretax income | -4.225 M | -4.099 M | -2.982 M | -2.736 M | -2.393 M | -2.193 M | -2.308 M | |
| -2.98% | -27.25% | -8.23% | -12.56% | -8.36% | 5.27% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.968 M | 2.516 M | -2.982 M | -2.803 M | -2.393 M | -2.193 M | -2.308 M | |
| 150.64% | -218.53% | 6.00% | 14.64% | 8.36% | -5.27% |
